Martin Lochner

1.2k total citations
47 papers, 874 citations indexed

About

Martin Lochner is a scholar working on Molecular Biology, Organic Chemistry and Sensory Systems. According to data from OpenAlex, Martin Lochner has authored 47 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Organic Chemistry and 9 papers in Sensory Systems. Recurrent topics in Martin Lochner's work include Receptor Mechanisms and Signaling (14 papers), Nicotinic Acetylcholine Receptors Study (12 papers) and Ion Channels and Receptors (8 papers). Martin Lochner is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Nicotinic Acetylcholine Receptors Study (12 papers) and Ion Channels and Receptors (8 papers). Martin Lochner collaborates with scholars based in Switzerland, United Kingdom and United States. Martin Lochner's co-authors include Andrew J. Thompson, Michele Leuenberger, Sarah C. R. Lummis, Matthias A. Hediger, Alexandre Simonin, Benjamin Clémençon, Yoshikatsu Kanai, Marc‐David Ruepp, Christine Peinelt and Sanjeev Kumar V. Vernekar and has published in prestigious journals such as Nature Communications, The Journal of Physical Chemistry B and Chemical Communications.

In The Last Decade

Martin Lochner

45 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Lochner Switzerland 14 491 202 159 129 121 47 874
Abhijeet Kapoor United States 13 391 0.8× 172 0.9× 153 1.0× 120 0.9× 183 1.5× 31 812
Michele Leuenberger Switzerland 12 374 0.8× 100 0.5× 216 1.4× 28 0.2× 128 1.1× 16 739
Yoko Nagumo Japan 23 615 1.3× 94 0.5× 358 2.3× 67 0.5× 49 0.4× 51 1.2k
Kumiko Takeuchi United States 17 433 0.9× 234 1.2× 207 1.3× 234 1.8× 24 0.2× 31 1.0k
Grazia Chiellini Italy 22 834 1.7× 338 1.7× 77 0.5× 97 0.8× 77 0.6× 47 1.8k
Sui‐Po Zhang United States 19 537 1.1× 416 2.1× 102 0.6× 141 1.1× 46 0.4× 45 976
Kazuya Kameo Japan 14 481 1.0× 210 1.0× 187 1.2× 28 0.2× 189 1.6× 28 1.1k
Roberta Gualdani Italy 15 448 0.9× 200 1.0× 50 0.3× 185 1.4× 19 0.2× 31 908
Szczepan Mogilski Poland 16 338 0.7× 168 0.8× 187 1.2× 31 0.2× 65 0.5× 48 700
T. Hansson Sweden 17 306 0.6× 184 0.9× 113 0.7× 33 0.3× 80 0.7× 33 885

Countries citing papers authored by Martin Lochner

Since Specialization
Citations

This map shows the geographic impact of Martin Lochner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lochner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lochner more than expected).

Fields of papers citing papers by Martin Lochner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Lochner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lochner. The network helps show where Martin Lochner may publish in the future.

Co-authorship network of co-authors of Martin Lochner

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Lochner. A scholar is included among the top collaborators of Martin Lochner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Lochner. Martin Lochner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Joachim, et al.. (2025). Investigation of the threonine metabolism of Echinococcus multilocularis: The threonine dehydrogenase as a potential drug target in alveolar echinococcosis. International Journal for Parasitology Drugs and Drug Resistance. 27. 100581–100581. 1 indexed citations
2.
Ekundayo, Babatunde, Sabrina Guichard, Martin Lochner, et al.. (2025). Identification of a binding site for small molecule inhibitors targeting human TRPM4. Nature Communications. 16(1). 833–833. 5 indexed citations
4.
Kaderli, Reto M., et al.. (2024). Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors In Vitro, In Vivo, and Ex Vivo. ACS Pharmacology & Translational Science. 7(5). 1557–1570.
5.
Bhardwaj, Rajesh, et al.. (2023). Development of chemical tools based on GSK-7975A to study store-operated calcium entry in cells. Cell Calcium. 117. 102834–102834. 2 indexed citations
6.
Rougier, Jean‐Sébastien, et al.. (2022). Targeting Ion Channel TRPM4. CHIMIA International Journal for Chemistry. 76(12). 1039–1039. 4 indexed citations
7.
Leuenberger, Michele, et al.. (2021). Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters. Journal of Pharmacology and Experimental Therapeutics. 377(3). 346–357. 8 indexed citations
8.
Lochner, Martin, et al.. (2021). Species-Specific Effects of Cation Channel TRPM4 Small-Molecule Inhibitors. Frontiers in Pharmacology. 12. 712354–712354. 25 indexed citations
9.
Bhardwaj, Rajesh, Palanivel Kandasamy, Roland Baur, et al.. (2020). Synthesis and Pharmacological Characterization of 2-Aminoethyl Diphenylborinate (2-APB) Derivatives for Inhibition of Store-Operated Calcium Entry (SOCE) in MDA-MB-231 Breast Cancer Cells. International Journal of Molecular Sciences. 21(16). 5604–5604. 19 indexed citations
10.
Beswick, Paul, et al.. (2019). A challenge finding P2X1 and P2X4 ligands. Neuropharmacology. 157. 107674–107674. 5 indexed citations
11.
Ruepp, Marc‐David, Hao Wei, Michele Leuenberger, Martin Lochner, & Andrew J. Thompson. (2017). The binding orientations of structurally-related ligands can differ; A cautionary note. Neuropharmacology. 119. 48–61. 16 indexed citations
12.
Thompson, Andrew J., et al.. (2017). The binding orientation of epibatidine at α7 nACh receptors. Neuropharmacology. 116. 421–428. 12 indexed citations
13.
Lochner, Martin & Andrew J. Thompson. (2016). The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT 3 receptors. Neuropharmacology. 108. 220–228. 60 indexed citations
14.
Humphreys, Sara C., Martin Lochner, Marc‐David Ruepp, et al.. (2015). Tracking individual membrane proteins and their biochemistry: The power of direct observation. Neuropharmacology. 98. 22–30. 12 indexed citations
15.
Lochner, Martin & Andrew J. Thompson. (2015). A review of fluorescent ligands for studying 5-HT3 receptors. Neuropharmacology. 98. 31–40. 9 indexed citations
16.
Kanai, Yoshikatsu, Benjamin Clémençon, Alexandre Simonin, et al.. (2013). The SLC1 high-affinity glutamate and neutral amino acid transporter family. Molecular Aspects of Medicine. 34(2-3). 108–120. 248 indexed citations
17.
Vernekar, Sanjeev Kumar V., Andrew J. Thompson, Joanne Hothersall, et al.. (2011). High-affinity fluorescent ligands for the 5-HT3 receptor. Bioorganic & Medicinal Chemistry Letters. 22(2). 1151–1155. 15 indexed citations
18.
Lochner, Martin & Sarah C. R. Lummis. (2010). Agonists and Antagonists Bind to an A-A Interface in the Heteromeric 5-HT3AB Receptor. Biophysical Journal. 98(8). 1494–1502. 44 indexed citations
19.
Thompson, Andrew J., Martin Lochner, & Sarah C. R. Lummis. (2008). Loop B Is a Major Structural Component of the 5-HT3 Receptor. Biophysical Journal. 95(12). 5728–5736. 23 indexed citations
20.
Thompson, Andrew J., Martin Lochner, & Sarah C. R. Lummis. (2007). The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5‐HT3 receptors. British Journal of Pharmacology. 151(5). 666–677. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026